Assembly Biosciences, Inc Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019 Call Transcript
Good day, ladies and gentlemen, and welcome to Assembly Bio EASL 2019 review. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the conference over to Lauren Glaser, Vice President of Investor Relations and Corporate Affairs. Ma'am, you may begin.
Thank you. Good afternoon to those connecting from Europe and good morning to everyone in U.S. Thank you for joining us today as we summarize and discuss our recent presentations at the 2019 International Liver Congress, the annual meeting of the European Association for the Study of the Liver, which concluded yesterday in Vienna.
I'm joined today by Derek Small, our President and Chief Executive Officer, who will provide open remarks momentarily; Dr. Richard Colonno, our Executive Vice President and Chief Scientific Officer of Biology Operations, who will provide a summary of the data presented at the EASL.
In addition, Dr. Uri Lopatin, our Chief Medical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
